Registry of antithrombotic therapy in patients with atrial fibrillation under replacement with bioprosthetic valve. (Retrospective observational study)
Not Applicable
- Conditions
- Patients with atrial fibrillation after replacement with bioprosthetic valve.
- Registration Number
- JPRN-UMIN000034198
- Lead Sponsor
- ational Cerebral and Cardiovascular Center DAIICHI SANKYO CO., LTD.
- Brief Summary
The mean observation period was 46.0 months. Warfarin was administered to 176 patients (82.2%), direct oral anticoagulants to 16 patients (7.5%), and antiplatelet drugs to 13 patients (6.1%). The number of patients who were treated with DOAC was increasing in the later period of registration. Stroke/systemic embolism was observed in 14 patients (1.77 patients/100 person-years [PY]). Major bleeding was observed in 22 patients (2.83/100 PY).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 214
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who were participating in an interventional study during the period for investigation 2) Patients who have a mechanical valve in their body
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of stroke/systemic embolism and major bleeding during the observation period
- Secondary Outcome Measures
Name Time Method